Connect with us
Psychedelic clinical research firm Alira Health will collaborate with the Scottsdale Research Institute (SRI) to provide regulatory and clinical support to bring clinical research of psilocybin...
Relmada Therapeutics Inc. (Nasdaq: RLMD) announced the publication of “promising” REL-1017 clinical data from the Reliance I Study in the peer-reviewed journal, The Journal of Clinical...
Atai’s proposal to purchase the company will serve as a stalking horse bid under the Sale and Investment Solicitation Process. IntelGenx Corp. (OTCQB: IGXT) (TSX: IGX)...
Nearly two months after sending out press releases that crowed about the company’s advancements, Numinus Wellness Inc. (OTC: NUMIF) walked back those claims and blamed its...
The Ninth Circuit will weigh whether “right-to-try” laws allow patients to access psychedelic substances. The Ninth Circuit Court of Appeals is set to hear arguments in...
The U.S. Food and Drug Administration warned consumers that certain mushroom-containing chocolate bars have been linked to illnesses in eight people across four states. In an...
The Institute for Clinical and Economic Review (ICER) recently posted its revised evidence report assessing the comparative clinical effectiveness and value of 3,4-Methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP, a...
A panel of independent health advisers convened Tuesday to consider a landmark proposal to approve MDMA as a treatment for post-traumatic stress disorder. In the end,...
The U.S. Government Accountability Office (GAO) told the Drug Enforcement Administration (DEA) that it needs to do a better job with religious exemption requests it gets...
Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) announced Health Canada and the United States Food and Drug Administration (FDA) authorization for a Phase 2 clinical...
